老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Corgi Genomics & Precision Medicine ETF
35.13
+0.1025
0.29%
成交量：
213
成交額：
7,554
市值：
263.49萬
市盈率：
- -
高：
35.45
開：
35.45
低：
35.13
收：
35.03
52周最高：
36.54
52周最低：
23.88
股本：
7.50萬
流通股本：
7.50萬
量比：
1.00
換手率：
0.28%
股息：
- -
股息率：
- -
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
賽默飛世爾預計，隨着生物製藥領域研發和生產的提振，其在印度的客户數量將增長15%至20%
路透中文
·
08/10
迄今最全質量最高的人類基因組序列構建完成
格隆汇
·
08/07
Devyser與意大利實驗室簽署合作協議
投资观察
·
08/06
LivaNova：預計交易將逐步提升氧合器產能，增強滿足客户未滿足需求的能力
美股速递
·
08/05
Vertex 擴大領導團隊，為下一階段增長注入強勁動力
投资观察
·
08/04
受診斷業務需求強勁推動，Revvity上調年度利潤和營收預期
路透中文
·
08/04
非阿片止痛藥新鋭Latigo(LTGO.US)IPO擬最高募資2.88億美元，Nav1.8抑制劑劍指福泰製藥(VRTX.US)百億市場
智通财经
·
08/04
AI賦能肺癌早篩診療升級 國產醫療機器人加速精準醫療落地 真健康醫療(02697)迎行業發展機遇
智通财经
·
08/04
福泰製藥重申2026年全年指引：GAAP與非GAAP研發、AI研發及銷售管理費用預期不變
美股速递
·
08/04
福泰製藥：基於現行關税法規，2026年指引中關税成本影響依然微乎其微
美股速递
·
08/04
Vertex憑藉囊性纖維化藥物的強勁表現上調年度營收預期
路透中文
·
08/04
美國研究綜述-艾伯維、亞馬遜、伊利姆納
路透中文
·
08/03
美國研究綜述-蘋果、亞馬遜、萬事達卡
路透中文
·
07/31
【特約大V】龔成：最新分析，6個高增長行業
金吾财讯
·
07/31
Alnylam下調2026年產品銷售預期後股價下跌
路透中文
·
07/30
阿爾尼拉姆製藥公司公布2026年第二季度財報，並重點回顧近期階段性進展
美股速递
·
07/30
AbCellera Biologics獲2800萬美元預付款及里程碑付款與階梯式版税
美股速递
·
07/29
AbCellera攜手福泰製藥，共同開發針對自身免疫疾病的多特異性T細胞接合器
美股速递
·
07/29
賽默飛世爾科技(TMO)股票7月28日收盤上漲3.20%：投資者必看的核心信息
TradingKey中文
·
07/29
美國食品藥品監督管理局（FDA）批准了Freenome公司用於結直腸癌篩查的血液檢測
路透中文
·
07/27
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/GNMX/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":35.1325,"timestamp":1789588800000,"preClose":35.03,"halted":0,"volume":213,"delay":0,"changeRate":0.002926063374250618,"floatShares":75000,"shares":75000,"eps":0,"marketStatus":"盤前交易","change":0.1025,"latestTime":"09-17 07:36:43 EDT","open":35.45,"high":35.45,"low":35.1325,"amount":7554,"amplitude":0.009064,"askPrice":55.86,"askSize":100,"bidPrice":14.13,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":35.1325,"nav":35.01,"aum":2625750,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.45,"preClose":35.1325,"latestTime":"16:10 EDT","volume":6,"amount":210.795,"timestamp":1789589404166,"change":0.3175,"changeRate":0.009037,"amplitude":0},"volumeRatio":1.0028255669672084,"impliedVol":0.4272,"impliedVolPercentile":0.7831},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":75000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0028255669672084,"shares":75000,"dividePrice":0,"high":35.45,"amplitude":0.009064,"preClose":35.03,"low":35.1325,"week52Low":23.88,"pbRate":"--","week52High":36.5366,"institutionHeld":0,"latestPrice":35.1325,"eps":0,"divideRate":0,"volume":213,"delay":0,"ttmEps":0,"open":35.45,"prevYearClose":25.56,"prevWeekClose":34.1467,"prevMonthClose":35.0802,"prevQuarterClose":31.0879,"fiveDayClose":34.4,"twentyDayClose":32.1297,"sixtyDayClose":28.0485},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNMX\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658867879","title":"賽默飛世爾預計，隨着生物製藥領域研發和生產的提振，其在印度的客户數量將增長15%至20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658867879","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658867879?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 16:07","pubTimestamp":1786349279,"startTime":"0","endTime":"0","summary":"赛默飞世尔预计，随着生物制药领域研发和生产的提振，其在印度的客户数量将增长15%至20%Rishika Sadam路透海得拉巴8月10日-赛默飞世尔科技印度分公司负责人表示，该公司计划在未来五年内将印度客户群扩大15%至20%，并押注于不断发展的生物制药研发与制造生态系统。该公司表示，受生物制药、半导体和清洁能源领域需求增长的推动，其在印度的业务有望持续实现两位数增长。赛默飞世尔为全球客户提供服务，美国是其主要市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4S4470DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1064131342.USD","LU2360108059.USD","LU2125910179.SGD","LU0342679015.USD","LU1923622291.USD","IE00BQXX3F31.USD","IE0034235188.USD","LU0640476718.USD","TMED","LU2125909247.SGD","LU0070302665.USD","LU0208291251.USD","LU1988902786.USD","TMO","HRTS","LU0234572021.USD","LU2720916845.USD","LU2764263203.CNY","GB00BDT5M118.USD","IE0002141913.USD","LU0557290698.USD","LU1548497426.USD","LU2764262908.HKD","BK4588","LU2092937221.SGD","LU2112291526.USD","GNMX","LU1815333072.USD","LU2089984988.USD","FMED","LU0345770993.USD","LU2357305700.SGD","IE00B1BXHZ80.USD","LU0266013472.USD","BK4581","LU2543165471.USD","LU1854104046.USD","LU1983299246.USD","BK4121","IE00BQXX3D17.EUR","IE00BJT1NW94.SGD","LU1803068623.USD","LU0096362180.USD","LU2211814178.USD","BK4548","LU0345770308.USD","LU1791710582.SGD","LU1989771016.USD","LU1670628061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661049","title":"迄今最全質量最高的人類基因組序列構建完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661049","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657661049?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 07:22","pubTimestamp":1786058531,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GNMX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173257026","title":"Devyser與意大利實驗室簽署合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1173257026","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173257026?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 14:40","pubTimestamp":1785998440,"startTime":"0","endTime":"0","summary":"8月6日，瑞典分子诊断公司Devyser Diagnostics AB宣布，已签署其首个商业试剂租赁协议。该协议在意大利落地，作为其与Illumina合作的一部分。此举标志着Devyser在全球市场拓展中迈出关键一步，尤其在南欧的意大利市场。通过这一合作，Devyser将提供基于Illumina平台的定制化试剂解决方案，旨在提升实验室的检测效率和灵活性。协议的具体财务条款尚未披露，但此类租赁模式通常能为客户降低初始投资成本，同时确保试剂供应的稳定性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILMN","BK4585","BK4121","LU0128526141.USD","BK4535","BK4534","BK4548","BK4588","GNMX","GNOM","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178169770","title":"LivaNova：預計交易將逐步提升氧合器產能，增強滿足客户未滿足需求的能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1178169770","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178169770?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 18:15","pubTimestamp":1785924909,"startTime":"0","endTime":"0","summary":"LivaNova宣布，一项交易预计将有助于逐步提升其氧合器的产量。随着时间的推移，这一举措将显著增强公司满足客户潜在且尚未被满足的订单需求的能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791710582.SGD","BK4566","IE00B1BXHZ80.USD","LU2125909759.SGD","LU0266013472.USD","BK4548","LU2125909247.SGD","LU1803068623.USD","LU2041044095.USD","LU0823416689.USD","GNMX","LU2360108059.USD","LU1791710400.SGD","IE00B19Z9505.USD","IE00B19Z8X17.USD","LU2433249047.HKD","LFSC","LU1720051017.SGD","BK4585","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4581","BK4535","LU0114720955.EUR","LU0070302665.USD","IE00BQXX3F31.USD","IE00BKPKM429.USD","LU2065170008.USD","LU1989771016.USD","LU0432979614.USD","IE00BQXX3D17.EUR","BK4588","LU0342679015.USD","LU2063271972.USD","LU1548497426.USD","LU1983299246.USD","LU0345770308.USD","LU0557290698.USD","LU2125909593.SGD","LU0011850046.USD","LU1670627923.USD","LU1923621640.USD","LU1061106388.HKD","LU2764262908.HKD","IE0009355771.USD","LU0320765489.SGD","LU2125909916.SGD","LU1057294990.SGD","LU1720051108.HKD","LU2764263203.CNY","TMED","LU2065171402.SGD","GB00BDT5M118.USD","LU2468319806.SGD","LU2092937221.SGD","BK4082","LU2357305700.SGD","LU1670628061.USD","LU1291159041.SGD","LU1280957306.USD","LU1854104046.USD","LU0345770993.USD","LU2125910336.SGD","LU0882574055.USD","TMO","IE00BJT1NW94.SGD","LU1923622614.USD","LU1815333072.USD","LU1854103824.USD","BK4534","FMED","LU1633808545.USD","LU1623119135.USD","HRTS","LU2125910179.SGD","IE00BQXX3C00.GBP","LU2764263039.SGD","IE0034235188.USD","BK4121","LU1153585028.USD","LU2211814178.USD","LU1923622291.USD","IE00BFTCPJ56.SGD","LU2298321311.HKD","LU0640476718.USD","LU1712237335.SGD","LU0208291251.USD","LU2112291526.USD","LU0234572021.USD","LU1023059063.AUD","LU2065171311.SGD","LU2720916845.USD","LU2543165471.USD","IE00B19Z8W00.USD","LU0122379950.USD","LIVN","LU0957791311.USD","LU2089984988.USD","LU0061474960.USD","BK4533","LU2065169927.USD","LU0316494557.USD","LU1988902786.USD","LU2211815571.USD","IE00B4R5TH58.HKD","LU2264538146.SGD","IE00B2B36J28.USD","LU0096362180.USD","LU1064131342.USD","LU0528227936.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117517951","title":"Vertex 擴大領導團隊，為下一階段增長注入強勁動力","url":"https://stock-news.laohu8.com/highlight/detail?id=1117517951","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117517951?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 20:02","pubTimestamp":1785844955,"startTime":"0","endTime":"0","summary":"宾夕法尼亚州普鲁士王，2026年8月4日——全球间接税与合规领域的“决策到防御”先锋，Vertex Inc.，今日宣布其领导团队迎来三位新成员，旨在为公司下一阶段的蓬勃发展提供坚实支撑。他们的加入，将通过对人才、区域运营及技术创新的领导力扩展，进一步强化 Vertex 的全球增长战略。在 Vertex，她将负责全球人才与企业文化战略，构建起推动业务规模化发展所需的人才储备和组织能力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","IE00BJT1NW94.SGD","BK4532","IE00B19Z3581.USD","TISI","LU1069344957.HKD","LU1674673428.USD","IE00BJJMRZ35.SGD","BK4099","BBH","LU0058720904.USD","IE0002270589.USD","BK4533","IE00B19Z9Z06.USD","LU2362541513.USD","SG9999001176.USD","LU1035775433.USD","PW","LU2089984988.USD","LU0079474960.USD","BK4120","LU2362540622.SGD","IE0009355771.USD","LU0109394709.USD","LU2468319806.SGD","TM","LU0061475181.USD","IE00B19Z3B42.SGD","LU2237438978.USD","LU0289739699.SGD","LU2417539215.USD","TBXU","LU1430594728.SGD","LU0234570918.USD","BK4139","BK4604","IE00BFTCPJ56.SGD","IE00B19Z9P08.USD","BK4567","LU1559883803.SGD","LU2324357040.USD","VERX","BK4588","BK4084","IE00B2B36J28.USD","LU1815336091.USD","IE0002141913.USD","BK4585","SGXZ57979304.SGD","LU1585245621.USD","IE00B4R5TH58.HKD","LU1778281490.HKD","LU0889565916.HKD","LU1093756325.SGD","LU0757428866.USD","LU2362541273.HKD","LU2462157665.USD","IE00BZ9MQY76.HKD","BK4234","BK4023","LU0320765992.SGD","BK4555","LU1093756168.USD","IE00B894F039.SGD","LU1674673691.USD","LU0432979614.USD","SG9999001176.SGD","IBBQ","SG9999013999.USD","GNMX","03160","PBE","LU0417517546.SGD","LU2456880835.USD","LU0256863811.USD","IDNA","VRTX","LU2236285917.USD","IBB","BIB","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656053712","title":"受診斷業務需求強勁推動，Revvity上調年度利潤和營收預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2656053712","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656053712?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 18:51","pubTimestamp":1785840687,"startTime":"0","endTime":"0","summary":"受诊断业务需求强劲推动，Revvity上调年度利润和营收预期路透8月4日-医疗设备制造商Revvity周二上调了年度利润和营收预期，此前受其药物研发工具和诊断检测产品需求改善的推动，该公司第二季度业绩超出华尔街预期。Revvity的诊断业务第二季度营收同比增长11%，达到3.71亿美元。Revvity还签署了一项协议，计划出售其在中国市场的免疫诊断业务，理由是该国诊断市场持续疲软。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4T4410UH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU1923622291.USD","GNMX","LU1923622614.USD","IE00B2B36J28.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","IE00B1BXHZ80.USD","LU0342679015.USD","LU2543165471.USD","LU2433249047.HKD","LU0266013472.USD","LU2468319806.SGD","TMO","LU1670628061.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","LU1791710400.SGD","IE00BQXX3D17.EUR","RVTY","FMED","IE00B19Z9505.USD","LU1064131342.USD","LU2764262908.HKD","LU1633808545.USD","LU1291159041.SGD","LU2764263039.SGD","LU2041044095.USD","BK4121","LU2092937221.SGD","LU2211814178.USD","IE00B4R5TH58.HKD","LU0528227936.USD","LU0316494557.USD","LU2125909247.SGD","LU1854104046.USD","LU2125909593.SGD","BK4535","LU2125909916.SGD","BK4533","LU2125910179.SGD","BK4581","TMED","LU2360108059.USD","HRTS","LU1548497426.USD","LU0122379950.USD","LU0882574055.USD","LU1153585028.USD","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656539622","title":"非阿片止痛藥新鋭Latigo(LTGO.US)IPO擬最高募資2.88億美元，Nav1.8抑制劑劍指福泰製藥(VRTX.US)百億市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2656539622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656539622?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 16:59","pubTimestamp":1785833974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2362541513.USD","IE00B19Z3B42.SGD","SG9999013999.USD","BK4127","LU0823416689.USD","LU0889565916.HKD","LU0256863811.USD","LU1585245621.USD","LU1778281490.HKD","VRTX","IE00BFTCPJ56.SGD","LU0058720904.USD","KCE","BK4588","IPOS","BK4533","LU0417517546.SGD","IE00B19Z9Z06.USD","LU2456880835.USD","BIB","BK4585","LU2362541273.HKD","LU1674673428.USD","IE00BZ9MQY76.HKD","IE00B4R5TH58.HKD","LU1093756168.USD","TBXU","IE00BJT1NW94.SGD","LU2324357040.USD","REDS","IE00BJJMRZ35.SGD","LTGO","IBB","IE0002141913.USD","BK4532","BK4139","IE00B19Z3581.USD","LU2468319806.SGD","LU1430594728.SGD","GNMX","IDNA","IBBQ","LU0289739699.SGD","SGXZ57979304.SGD","BBH","FRHC","LU1093756325.SGD","LU0234570918.USD","IE00B19Z9P08.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656584164","title":"AI賦能肺癌早篩診療升級 國產醫療機器人加速精準醫療落地 真健康醫療(02697)迎行業發展機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2656584164","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656584164?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 12:58","pubTimestamp":1785819500,"startTime":"0","endTime":"0","summary":"业内人士认为，随着AI影像识别、三维重建、机器人辅助介入等技术持续成熟，医疗机器人产业正加速迈入商业化应用阶段，覆盖肺癌、骨科、神经外科等多个高价值赛道，行业成长空间广阔。受益于医疗智能化升级趋势，“穿刺手术机器人第一股”真健康医疗持续推进人工智能与数字医疗布局。随着国家持续推动医疗数字化建设，以及AI医疗机器人、精准诊疗等新技术加速落地，真健康医疗有望受益于行业景气度提升，进一步打开长期成长空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475645.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","ARTY","DTEC","HELX","AIPO","XT","159891","BK1100","TYNE","CHAT","02697","GNMX","QTOC","WDNA","VTHR","HTEC","IDNA","GDOC","GNOM","KOMP","SYNB","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126575276","title":"福泰製藥重申2026年全年指引：GAAP與非GAAP研發、AI研發及銷售管理費用預期不變","url":"https://stock-news.laohu8.com/highlight/detail?id=1126575276","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126575276?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 04:07","pubTimestamp":1785787669,"startTime":"0","endTime":"0","summary":"福泰制药（Vertex Pharmaceuticals）再次确认其2026年全年财务指引。在涵盖GAAP及非GAAP口径下的研发支出、AI研发投入以及销售、一般及管理费用（SG&A）方面，该公司均维持此前预期不变，未作出任何调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","LU0289739699.SGD","GNMX","IE00B4R5TH58.HKD","LU1430594728.SGD","LU0109394709.USD","IE00B894F039.SGD","BK4532","LU0234570918.USD","IBBQ","LU1069344957.HKD","LU1585245621.USD","BK4139","LU1093756168.USD","VRTX","LU2362540622.SGD","LU2236285917.USD","SGXZ57979304.SGD","LU0079474960.USD","BK4588","IE00B19Z9Z06.USD","PBE","LU1093756325.SGD","LU2362541513.USD","IE00BZ9MQY76.HKD","LU2362541273.HKD","SG9999001176.USD","BK4585","LU2462157665.USD","SG9999001176.SGD","IE0002141913.USD","IE0009355771.USD","LU1674673691.USD","LU2237438978.USD","IE00B19Z3581.USD","LU0417517546.SGD","TBXU","IE00BJJMRZ35.SGD","BBH","LU2324357040.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU0058720904.USD","LU1778281490.HKD","LU0889565916.HKD","IE0002270589.USD","IE00B19Z3B42.SGD","BK4567","BIB","IE00BJT1NW94.SGD","IDNA","LU1035775433.USD","LU0256863811.USD","LU0320765992.SGD","LU2417539215.USD","LU0432979614.USD","LU0061475181.USD","IBB","LU2456880835.USD","LU2089984988.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","SG9999013999.USD","LU1674673428.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141963964","title":"福泰製藥：基於現行關税法規，2026年指引中關税成本影響依然微乎其微","url":"https://stock-news.laohu8.com/highlight/detail?id=1141963964","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141963964?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 04:04","pubTimestamp":1785787449,"startTime":"0","endTime":"0","summary":"福泰制药（Vertex Pharmaceuticals）表示，根据当前已知的关税税率与相关法规，其2026年业绩指引中继续纳入的关税成本影响，仍属微不足道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU2362540622.SGD","BK4533","BIB","IE00BZ9MQY76.HKD","LU0061475181.USD","PBE","IDNA","IBB","SG9999013999.USD","IE00BJJMRZ35.SGD","GNMX","BK4139","LU0823416689.USD","IE00B4R5TH58.HKD","BK4585","IE00B19Z3B42.SGD","BK4588","IE00BFTCPJ56.SGD","LU2417539215.USD","LU2462157665.USD","IE00B19Z9Z06.USD","LU0417517546.SGD","LU1069344957.HKD","LU1035775433.USD","LU1674673428.USD","LU2362541513.USD","LU1778281490.HKD","SG9999001176.USD","SGXZ57979304.SGD","TBXU","LU0432979614.USD","LU2456880835.USD","LU0289739699.SGD","LU1093756325.SGD","BBH","LU1674673691.USD","LU1430594728.SGD","IE0002141913.USD","LU2362541273.HKD","SG9999001176.SGD","VRTX","LU1093756168.USD","LU2237438978.USD","LU0320765992.SGD","LU0889565916.HKD","LU0234570918.USD","LU1585245621.USD","LU0256863811.USD","LU2324357040.USD","IBBQ","LU0109394709.USD","LU0058720904.USD","IE0002270589.USD","LU2236285917.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU2089984988.USD","IE00B19Z3581.USD","BK4532","LU2468319806.SGD","BK4567","IE00B19Z9P08.USD","IE00B894F039.SGD","LU0079474960.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656630972","title":"Vertex憑藉囊性纖維化藥物的強勁表現上調年度營收預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2656630972","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656630972?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 04:02","pubTimestamp":1785787378,"startTime":"0","endTime":"0","summary":"Vertex凭借囊性纤维化药物的强劲表现上调年度营收预期路透8月3日-Vertex Pharmaceuticals周一上调了年度营收预期的上限，此举得益于其囊性纤维化治疗药物需求的强劲增长。Vertex表示，其年度展望未包含待完成的Crinetics收购交易，待交易于第三季度完成后，将提供更新后的预测。该公司表示，这一增长主要得益于囊性纤维化疗法的持续良好表现。Vertex报告称，经调整后的季度每股收益为4.73美元，符合市场预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4T4401T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","IE00BJT1NW94.SGD","LU0234570918.USD","LU1430594728.SGD","LU2468319806.SGD","BBH","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","LU2324357040.USD","LU2362541513.USD","IBBQ","LU0417517546.SGD","TBXU","IE00B2B36J28.USD","LU2417539215.USD","SG9999001176.USD","IE0002141913.USD","IE0002270589.USD","LU2362541273.HKD","CRNX","LU0079474960.USD","LU1093756325.SGD","BIB","PBE","IE00BZ9MQY76.HKD","IDNA","LU0432979614.USD","GNMX","BK4585","SG9999001176.SGD","BK4007","IBB","VRTX","LU0320765992.SGD","LU1035775433.USD","LU0289739699.SGD","LU1778281490.HKD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","IE00B19Z9P08.USD","BK4567","IE00B4R5TH58.HKD","BK4532","LU2362540622.SGD","IE00B894F039.SGD","LU0256863811.USD","SG9999013999.USD","LU1069344957.HKD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656329979","title":"美國研究綜述-艾伯維、亞馬遜、伊利姆納","url":"https://stock-news.laohu8.com/highlight/detail?id=2656329979","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656329979?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 15:47","pubTimestamp":1785743242,"startTime":"0","endTime":"0","summary":"美国研究综述-艾伯维、亚马逊、伊利姆纳路透8月3日-周一，华尔街证券分析师下调了包括艾伯维、亚马逊和伊利姆纳在内的多家美国上市公司评级及目标股价。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4S4400J4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","IYF","CFR","ARES","PRM","PJP","AGIO","KOD","LBO","LAUR","VLY","GNOM","GNMX","INO","TFNS","NBN","ILMN","CBNA","BBT","FLG","LSEG.UK","GTES","CATY","RTH","ILDR","BN","IONS","ONLN","VCYT","MTZ","PFG","CL","WANT","BEPC","ABBV","FTXH","OMCL","FHN","BOKF","IR","TW","LNC","TRUH","MSA","FULT","CHD","AMZN","IYH","TEM","LH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655835829","title":"美國研究綜述-蘋果、亞馬遜、萬事達卡","url":"https://stock-news.laohu8.com/highlight/detail?id=2655835829","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655835829?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 15:15","pubTimestamp":1785482121,"startTime":"0","endTime":"0","summary":"美国研究综述-苹果、亚马逊、万事达卡路透7月31日-周五，华尔街证券分析师下调了包括苹果、亚马逊和万事达卡在内的多家美国上市公司评级及目标股价。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4T43X0O3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARXS","LBO","CLIX","CRS","AX","FCF","BITQ","ALRS","CHDN","AMZN","H","GH","BHRB","CORZ","TREE","AVY","HSY","CMCO","GNMX","CSW","GDDY","HULL","ALNY","DAPP","KPTI","XLK","DXCM","AAPL","GPI","COIA","CUT","BXMT","CWH","ILMN","AJG","SPTE","DXC","ESS","DRS","BUSE","FMC","BMY","EXPO","COIN","CFR","KKR","GDYN","BELFB","FLS","IP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655334630","title":"【特約大V】龔成：最新分析，6個高增長行業","url":"https://stock-news.laohu8.com/highlight/detail?id=2655334630","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655334630?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 13:21","pubTimestamp":1785475308,"startTime":"0","endTime":"0","summary":"行业现仍处于发展阶段。目前持有超过400万枚以太币。这不仅节省长期用药开支，更大幅改善病人生活品质，市场价值极高。研发成功可赚取巨利，失败则股价大跌。绝大部分尚未有商业化产品，无明显收入，持续烧钱下资金链可能出现问题。--6. 核能：AI数据中心的电力答案--最后一个行业是核能产业。受惠于碳中和趋势及AI数据中心的庞大用电需求，核能正快速增长。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987233","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSH","TEST","LU2097828631.EUR","HK0000914660.USD","TSLG","LU0611395673.USD","LU0097036916.USD","LU0077335932.USD","LU2778985437.USD","BK4600","BK4595","LU1914381329.SGD","LU0528227936.USD","LU1066051225.USD","HK0000286598.CNH","UUUU","NLR","LU2360108059.USD","LU2764263203.CNY","BK4539","BK1523","LU0593848301.USD","LU0640476718.USD","LU0823041008.USD","LU1668664300.SGD","TMED","CRCD","COIN","LU0133085943.USD","GASZ","LU0871576103.HKD","LU1481107354.HKD","LU1923622614.USD","BK1618","IE0002141913.USD","LU0169518387.USD","LU0820562030.AUD","QBTX","BK1193","LU2087589342.USD","LU2360107168.USD","LU0348827113.USD","LU2065170008.USD","QTUP","TSL","LU2294711713.HKD","LU0235996351.USD","BK4591","LU2168564495.EUR","LU1153585028.USD","LU1105468828.SGD","IE0034235188.USD","CNRG","LU1868837565.USD","LU0823426480.USD","URAN","LU2417539215.USD","IE00BQXX3D17.EUR","LU1770034418.SGD","URNJ","BK4550","09880","BK1610","COYY","LU2168563687.JPY","LU0266013472.USD","BK4099","SG9999001093.SGD","SMOG","LU1282648689.USD","LU0417516738.SGD","DAPP","BK4554","TLA","BK1613","LU2471134796.USD","IE00BWXC8680.SGD","IONX","PACB","IE00B4R5TH58.HKD","BK4023","TSLA","BEAM","LU0499858438.USD","BKCH","LU2213496289.HKD","BK1506","LU0348825331.USD","LU0359202008.SGD","LU0320765489.SGD","LU1093756168.USD","LU1429558221.USD","IE00BJT1NW94.SGD","LU1988902786.USD","IONQ","LU2039709279.SGD","HRTS","LU0198837287.USD","LU2211814178.USD","LU1861559042.SGD","LU2433249047.HKD","QBY","BK4611","LU2226246903.HKD","LU2125910179.SGD","LU2168564149.EUR","LU0210536198.USD","LU2087621335.USD","LU1880383366.USD","GEVX","LU1989771016.USD","LU0531970944.HKD","LU2152927971.USD","HK0000914686.HKD","IDRV","LU0441854154.USD","TSDD","LU0208291251.USD","LU1280957306.USD","LU0164880469.USD","SMRF","CONL","LEU","LU1435385759.SGD","LU1794554557.SGD","EXI","LU0540923850.HKD","GNMX","BK4566","LU2125910336.SGD","POWR","BK4596","CRCO","09766","FDRV","LU2125909593.SGD","LU0128526141.USD","LU0708995583.HKD","IE0009355771.USD","BK1615","LU0345770308.USD","WANT","JOUL","BK4112","LU0634319403.HKD","LU0320764599.SGD","LU0432979614.USD","LU2097828474.EUR","HXXD.SI","LU2403377893.USD","LU2471134952.CNY","LU0594300179.USD","LU2097828714.EUR","IE00BK4W5M84.HKD","SG9999015978.USD","LU1674673691.USD","07766","LU0823414478.USD","LU0466842654.USD","LU1880383440.USD","TSLI","ICRC","BK4556","LU0943347566.SGD","COII","LU0234570918.USD","TESL","LU0070302665.USD","HK0000165453.HKD","LU0823414551.USD","IE00BQXX3F31.USD","LU0096362180.USD","LU2543165471.USD","BK1183","LU2236285917.USD","IE0034224299.USD","LU0348814723.USD","09366","QBTZ","LU0689472784.USD","LU1188198961.HKD","LU1057294990.SGD","LU1813983027.USD","LU0053666078.USD","LU2092937221.SGD","LU0164865239.USD","BMNR","LU0348816934.USD","LU1251922891.USD","CRCG","TSLQ","LU0143863784.USD","BK4551","LU2750360997.AUD","LU0463099449.HKD","ILMN","LU0719512351.SGD","LU0724618433.USD","WATS","LU0823426308.USD","81810","LU2097828557.USD","RGTZ","LU0061474960.USD","LU1548497426.USD","BK4602","SG9999015945.SGD","LU1551013342.USD","FIAT","LU0084288322.USD","IONL","LU0117841782.USD","LU2896262040.SGD","LU2108987350.USD","BMNZ","COIA","LU0114720955.EUR","LU0054450605.USD","LU1629891620.HKD","LU0823413587.USD","LU2065169927.USD","IE00BJJMRZ35.SGD","LU2294711473.HKD","LU1852331112.SGD","TSLY","LU0307460666.USD","FRNW","LU2750360641.GBP","LU1861215975.USD","BK4170","LU1303224171.USD","BK4598","LU2041044095.USD","RGTI","IE00B19Z9505.USD","LU2290526834.HKD","LU0052750758.USD","LU0082616367.USD","LU1023059063.AUD","LU1633808545.USD","LU0214875030.USD","LU2399975544.HKD","IBLC","LU1791710582.SGD","TSLS","LU0327786744.USD","LU1232071149.USD","LU0359201885.HKD","LU2097828805.USD","LU0823040885.USD","LU1839511570.USD","BK4527","LU0342679015.USD","LU1720051108.HKD","MIUmain","WQTM","URNM","LU2063271972.USD","LU0348723411.USD","YBMN","LU0823411888.USD","IE00B3M56506.USD","LU1861558580.USD","FINX","LU0106831901.USD","LU0231483743.USD","LU0056508442.USD","LU2298321311.HKD","SG9999002463.SGD","DRGN","LU1064131342.USD","LU1066051498.USD","LU0164872284.USD","CONY","LU1145028129.USD","LU0124384867.USD","GB00BDT5M118.USD","IOYY","LU0314109678.HKD","LU0320765059.SGD","TSLZ","LU0561508036.HKD","BK4511","LU1803068623.USD","LU2249611893.SGD","LU2471134523.USD","LU1978683503.SGD","LU1720050803.USD","LU1291159041.SGD","RCTR","CQTM","LU2720916845.USD","TSYY","LIT","LU0244354667.USD","LU1066053197.SGD","LU0359201612.USD","LU0918141705.HKD","LU1719994722.HKD","BMNU","LU1956131251.USD","UUUG","IE00BSNM7G36.USD","LU0210526637.USD","BK4581","LU0234572021.USD","LU0348735423.USD","OKLS","LU0345770993.USD","LU0588546209.SGD","LU2257852520.SGD","LU2250418816.HKD","URA","LU2764263039.SGD","ICOI","BK4535","LU2023250330.USD","LU0029874061.USD","LU1854103824.USD","CONI","LU0149721374.USD","BK4156","IE00B19Z8W00.USD","LU0823397285.USD","LU2168564222.USD","TSLW","SG9999015952.SGD","BK4585","LU0326950275.SGD","LU0700851271.USD","LU0594300419.USD","BK4548","07366","LEUX","FMED","LU0823416689.USD","XME","XIACY","LU0823039010.USD","RGYY","LU1854104046.USD","LU1061106388.HKD","OKLO","BK4612","SG9999015986.USD","LU2471134879.HKD","TSLR","LU0345775950.USD","BK4604","LU0531971595.HKD","BK1589","FDIG","IE0004091025.USD","IE00BQXX3C00.GBP","IONZ","LU0964807845.USD","LU1861220207.SGD","LU0122379950.USD","LU2112291526.USD","BK4592","LU0345769631.USD","LU1720051017.SGD","LU1791807156.HKD","LU2326559502.SGD","CRPT","LU1066051811.HKD","LU2360106780.USD","LU0254981946.USD","LU2168564065.EUR","LU2456880835.USD","LU2357125470.USD","BK4533","BK4555","LU1923621640.USD","BK4141","OKLL","BK4606","LU0109391861.USD","LU2065171311.SGD","CRCA","LU0323591593.USD","TRUI","BK4182","TSLO","BLCK","LU2065171402.SGD","LU2357305700.SGD","LU2602419157.SGD","LU0345776255.USD","LU0456827905.SGD","LU1791710400.SGD","BK1502","LU0316494557.USD","LU0675040207.SGD","LU0708995401.HKD","LU2420271590.USD","TSLL","TSLP","LU1323998911.USD","BK1607","LU0882574055.USD","LU2125909916.SGD","LU0039217434.USD","QBTS","IE00B2B36J28.USD","LU1267930730.SGD","LU2756315664.SGD","BK4147","LU1303367103.USD","LU0417516902.SGD","LU1623119135.USD","LU2125909247.SGD","IE0004086264.USD","UXI","LU0011850046.USD","BK4139","BK1575","BK4608","LU1815333072.USD","LU2089984988.USD","IE0034235303.USD","CCUP","LU0918141887.USD","RGTU","IE00BKPKM429.USD","BK4121","LU1778281490.HKD","BK4534","LU0823413660.USD","LU2468319806.SGD","NUKX","IE00B19Z8X17.USD","LU1023057109.AUD","LU1923622291.USD","LU1961090484.USD","TMO","LU0499858602.USD","LU2098885051.SGD","RGTX","LU2756315318.SGD","BK4081","LU2476274308.USD","LU2476274720.SGD","IE00B1BXHZ80.USD","BMNG","LU0650527681.SGD","BK1521","LU1868838027.USD","BK4516","LU0820561818.USD","LU1861217088.USD","LU0823397103.USD","CONX","GEV","LU1551013425.SGD","SG9999003461.SGD","LU1670627923.USD","LU0672654240.SGD","LU1808992512.USD","LU1328277881.USD","01810","IE00B1XK9C88.USD","LU1861220033.SGD","LU0797268264.HKD","LU2360107671.USD","TSLT","LU0957791311.USD","IE00BFTCPJ56.SGD","PUI","LU0557290698.USD","BK4563","LU0456846285.SGD","LU0211977185.USD","LU2125909759.SGD","IE00BJLML261.HKD","LU2462157665.USD","BK4574","TSII","COIG","LU0572944931.SGD","COIO","CRCL","LU2506951792.HKD","LU1981816686.USD","LU0449515922.USD","GNOM","LU0820561909.HKD","LU2764262908.HKD","GEVG","LU1770036033.HKD","LU0605514214.HKD","LU2298322129.HKD","LU2211815571.USD","LU0449509016.USD","LU0823038988.USD","BK4588","LU0345769128.USD","LU1983299246.USD","LU2264538146.SGD","IE00BK4W5L77.USD","LU1712237335.SGD","BITQ","LU1093756325.SGD","COIW","BK4505","IE0032431581.USD","LU1366192091.USD","LU0143863198.USD","LU1674673428.USD","LU1670628061.USD","BK4543","LU0051755006.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655773978","title":"Alnylam下調2026年產品銷售預期後股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2655773978","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655773978?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 20:24","pubTimestamp":1785414259,"startTime":"0","endTime":"0","summary":"BUZZ-Alnylam下调2026年产品销售预期后股价下跌7月30日-** 制药公司Alnylam Pharmaceuticals（ALNY.O）的股价在盘前交易中下跌21.5%，至225.00美元** 该公司将2026年产品总净收入预期从此前预估的49亿至53亿美元下调至47亿至51亿美元** 第二季度销售额为1.29亿美元，低于分析师预期的1.32亿美元——据伦敦证券交易所集团（LSEG）数据** 报告显示第二季度调整后每股收益为1.84美元，高于1.55美元的预期** 截至上一交易日收盘，该股年内累计跌幅达27.9%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL4S43W1H5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0109394709.USD","BK4548","LU0320765992.SGD","BK4139","LU0114720955.EUR","LU0882574055.USD","ALNY","PBE","BK4588","LU0889565916.HKD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175560090","title":"阿爾尼拉姆製藥公司公布2026年第二季度財報，並重點回顧近期階段性進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1175560090","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175560090?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 20:02","pubTimestamp":1785412965,"startTime":"0","endTime":"0","summary":"阿尔尼拉姆制药公司于近日正式披露了2026年第二季度的财务业绩。与此同时，该公司还着重梳理了在过去一段时间内所取得的各项关键进展。在回顾近期发展时，阿尔尼拉姆强调，其针对多项罕见病及常见疾病的RNAi疗法研究已进入新的里程碑阶段。总体而言，这段时期标志着阿尔尼拉姆在科学探索与商业价值实现上均迈出了坚实的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","BK4139","LU0114720955.EUR","LU0109394709.USD","BK4548","BK4588","BK4585","PBE","GNMX","LU0889565916.HKD","ALNY","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185330982","title":"AbCellera Biologics獲2800萬美元預付款及里程碑付款與階梯式版税","url":"https://stock-news.laohu8.com/highlight/detail?id=1185330982","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185330982?lang=zh_tw&edition=fundamental","pubTime":"2026-07-29 19:06","pubTimestamp":1785323188,"startTime":"0","endTime":"0","summary":"AbCellera Biologics公司宣布，将收到一笔高达2800万美元的预付款。除此之外，还有里程碑付款以及阶梯式特许权使用费加持。这笔交易架构颇为复杂，既有前期现金注入，也有后续潜在收益。预付款即刻到账，为研发管线提供弹药。里程碑款项则与特定项目进展挂钩，分期兑现。至于阶梯式版税，会随着产品销售额的攀升而逐步增加。整体来看，这一支付安排既保障了短期资金流，又锁定了长期回报空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0058720904.USD","LU2462157665.USD","LU2362541273.HKD","SG9999001176.SGD","IBB","VRTX","LU2324357040.USD","BK4567","LU0061475181.USD","LU2456880835.USD","SG9999001176.USD","BK4139","IE00B19Z3581.USD","BK4533","BK4532","LU0320765992.SGD","LU1035775433.USD","LU1093756325.SGD","PBE","BK4535","IE00B19Z3B42.SGD","LU0889565916.HKD","ABCL","BIB","LU2236285917.USD","LU0432979614.USD","BK4121","IE00BZ9MQY76.HKD","LU1674673691.USD","LU1674673428.USD","TBXU","LU2362540622.SGD","LU2237438978.USD","LU0256863811.USD","LU0823416689.USD","IE0002270589.USD","LU0289739699.SGD","LU1069344957.HKD","LU1093756168.USD","LU1778281490.HKD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","BK4585","IE00B894F039.SGD","IE00BFTCPJ56.SGD","LU0079474960.USD","IBBQ","BBH","BK4588","LU0417517546.SGD","LU1430594728.SGD","LU1585245621.USD","GNMX","LU2362541513.USD","IE0009355771.USD","LU2417539215.USD","SG9999013999.USD","IE00BJT1NW94.SGD","LU0234570918.USD","IE00B19Z9P08.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","SGXZ57979304.SGD","IDNA","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147206442","title":"AbCellera攜手福泰製藥，共同開發針對自身免疫疾病的多特異性T細胞接合器","url":"https://stock-news.laohu8.com/highlight/detail?id=1147206442","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147206442?lang=zh_tw&edition=fundamental","pubTime":"2026-07-29 19:01","pubTimestamp":1785322903,"startTime":"0","endTime":"0","summary":"AbCellera宣布与福泰制药达成合作，旨在共同探索和发现针对自身免疫性疾病及其他适应症的多特异性T细胞接合器。这一战略合作将结合双方的技术优势，致力于在治疗领域开拓创新路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","IBB","PBE","IE00B19Z9P08.USD","LU0256863811.USD","LU0320765992.SGD","LU0109394709.USD","LU0061475181.USD","LU2236285917.USD","IDNA","LU2462157665.USD","LU1674673691.USD","LU1585245621.USD","ABCL","BK4585","LU1093756168.USD","LU1093756325.SGD","BIB","IE00B19Z3581.USD","IBBQ","IE00BJT1NW94.SGD","LU1674673428.USD","LU2456880835.USD","LU2362541513.USD","LU0823416689.USD","LU0234570918.USD","LU0889565916.HKD","TBXU","LU2324357040.USD","IE0002141913.USD","SG9999013999.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","LU0417517546.SGD","IE00B19Z3B42.SGD","BK4121","IE00BFTCPJ56.SGD","LU2237438978.USD","LU2362541273.HKD","IE0009355771.USD","IE00B894F039.SGD","LU1069344957.HKD","IE00B2B36J28.USD","BK4139","LU1430594728.SGD","LU0432979614.USD","GNMX","BK4567","IE00B4R5TH58.HKD","IE0002270589.USD","LU0079474960.USD","BK4533","LU2417539215.USD","LU2362540622.SGD","BBH","SG9999001176.USD","SGXZ57979304.SGD","LU0289739699.SGD","SG9999001176.SGD","VRTX","BK4532","BK4588","BK4535","LU1778281490.HKD","IE00B19Z9Z06.USD","LU1035775433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655833949","title":"賽默飛世爾科技(TMO)股票7月28日收盤上漲3.20%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2655833949","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655833949?lang=zh_tw&edition=fundamental","pubTime":"2026-07-29 04:16","pubTimestamp":1785269797,"startTime":"0","endTime":"0","summary":"• 赛默飞世尔季度盈利超预期，并上调了全年有机营收指引。\n• 制药行业资本支出的增加以及对临床服务需求的上升，提振了公司的积压订单。\n• 技术指标释放出买入信号，分析师平均目标价为634.52美元。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262059555-market-movers-tmo-20260728","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051108.HKD","LU2125909247.SGD","LU1057294990.SGD","LU1548497426.USD","LU2720916845.USD","FMED","BK4121","LU1803068623.USD","LU1923621640.USD","LU2125909916.SGD","LU0528227936.USD","LU1988902786.USD","LU2211814178.USD","LU0320765489.SGD","LU2357305700.SGD","HRTS","LU1623119135.USD","LU1291159041.SGD","LU0096362180.USD","LU0823416689.USD","LU2125909759.SGD","IE00B4R5TH58.HKD","LU2298321311.HKD","BK4534","LU2089984988.USD","LU2764263203.CNY","LU0061474960.USD","IE00B19Z9505.USD","IE00B2B36J28.USD","LU1815333072.USD","LU2125910179.SGD","GNMX","IE0034235188.USD","LU2211815571.USD","LU2543165471.USD","LU2433249047.HKD","TMO","LU0882574055.USD","LU2468319806.SGD","LU0957791311.USD","TMED","LU1923622614.USD","LU1061106388.HKD","LU2264538146.SGD","IE00BJJMRZ35.SGD","LU0011850046.USD","LU1153585028.USD","LU0345770993.USD","LU0342679015.USD","LU2764263039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654048086","title":"美國食品藥品監督管理局（FDA）批准了Freenome公司用於結直腸癌篩查的血液檢測","url":"https://stock-news.laohu8.com/highlight/detail?id=2654048086","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654048086?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 21:13","pubTimestamp":1785157998,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局批准了Freenome公司用于结直肠癌筛查的血液检测路透7月27日-两家公司周一表示，美国食品药品监督管理局已批准Freenome公司针对年龄较大的成年人的FRNM.O血液结直肠癌筛查检测，为合作伙伴雅培公司今秋在美国推出该产品铺平了道路。美国食品药品监督管理局批准该检测适用于45岁及以上中风险成年人，这使Freenome拥有了其首个商业化产品。根据2025年签署的商业化协议，Freenome将从雅培公司获得与此次批准相关的1亿美元里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4T43T12N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721429741.USD","IHI","LU0058720904.USD","LU2237957902.USD","HELX","BK4568","IE00BJJMRZ35.SGD","LU1989763690.USD","SG9999004303.SGD","TMED","LU0170899867.USD","BK4082","BK4566","PJP","BK4551","LU2112291526.USD","LU0432979614.USD","LU0266013472.USD","LU2237957811.SGD","SGXZ23171101.USD","LU0868494617.USD","GNOM","BK4588","LFSC","LU0320765992.SGD","LU0234572021.USD","SG9999002224.SGD","GNMX","LU0882574055.USD","LU0122379950.USD","LU1989763427.SGD","LU2211815571.USD","LU1914381329.SGD","GDOC","LU0889565916.HKD","SG9999002232.USD","LU2133065610.SGD","BK4533","LU1061106388.HKD","PTH","GH","FRNM","IE00B2B36J28.USD","EKG","LU2468319806.SGD","IE0002141913.USD","ABT","BK4585","BK4535","FFOX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":78,"code":"91000000","status":"200"}]}}